Continuous Glucose Monitor, Implanted, Adjunctive Use
QCD is the FDA product code for Continuous Glucose Monitor, Implanted, Adjunctive Use, a class III device type. FDA's definition for this code reads: "The device is a fully implanted continuous glucose monitoring device intended to detect trends and track patterns in interstitial glucose values. The device is indicated for use as an adjunctive device to complement, not replace, information obtained from standard home blood glucose monitoring devices". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- QCD
- Device name
- Continuous Glucose Monitor, Implanted, Adjunctive Use
- FDA definition
- The device is a fully implanted continuous glucose monitoring device intended to detect trends and track patterns in interstitial glucose values. The device is indicated for use as an adjunctive device to complement, not replace, information obtained from standard home blood glucose monitoring devices.
- Device class
- Class III
- Review panel
- Unknown
- Submission type
- PMA
- Implant
- Yes
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
